DK1213972T3 - Komposition omfattende en alfa-amylase-inhibitor og mindst en fysiologisk acceptabel forbindelse, der kan nedsætte absorptionen af "hurtigere sukkere" i tarmen - Google Patents
Komposition omfattende en alfa-amylase-inhibitor og mindst en fysiologisk acceptabel forbindelse, der kan nedsætte absorptionen af "hurtigere sukkere" i tarmenInfo
- Publication number
- DK1213972T3 DK1213972T3 DK00958855T DK00958855T DK1213972T3 DK 1213972 T3 DK1213972 T3 DK 1213972T3 DK 00958855 T DK00958855 T DK 00958855T DK 00958855 T DK00958855 T DK 00958855T DK 1213972 T3 DK1213972 T3 DK 1213972T3
- Authority
- DK
- Denmark
- Prior art keywords
- sugars
- alpha
- physiologically acceptable
- acceptable compound
- amylase inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Enzymes And Modification Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9921229.2A GB9921229D0 (en) | 1999-09-08 | 1999-09-08 | Compositions |
| PCT/GB2000/003472 WO2001017369A1 (en) | 1999-09-08 | 2000-09-08 | Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of 'fast sugars' |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1213972T3 true DK1213972T3 (da) | 2003-08-18 |
Family
ID=10860574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00958855T DK1213972T3 (da) | 1999-09-08 | 2000-09-08 | Komposition omfattende en alfa-amylase-inhibitor og mindst en fysiologisk acceptabel forbindelse, der kan nedsætte absorptionen af "hurtigere sukkere" i tarmen |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1213972B1 (da) |
| JP (1) | JP2003508467A (da) |
| KR (1) | KR100594520B1 (da) |
| AT (1) | ATE238689T1 (da) |
| AU (1) | AU777044B2 (da) |
| CA (1) | CA2383720A1 (da) |
| DE (1) | DE60002484T2 (da) |
| DK (1) | DK1213972T3 (da) |
| ES (1) | ES2199174T3 (da) |
| GB (2) | GB9921229D0 (da) |
| NO (1) | NO314922B1 (da) |
| NZ (1) | NZ518167A (da) |
| PT (1) | PT1213972E (da) |
| WO (1) | WO2001017369A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7217556B1 (en) | 2000-12-23 | 2007-05-15 | Pfizer Inc | Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease |
| US7601528B1 (en) | 2000-12-23 | 2009-10-13 | Elan Pharmaceuticals, Inc. | Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease |
| US7384773B1 (en) | 2001-05-10 | 2008-06-10 | Pfizer Inc | Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof |
| US6797287B2 (en) | 2001-09-25 | 2004-09-28 | Pharmachem Laboratories, Inc. | Phaseolamin compositions and methods for using the same |
| US7108869B2 (en) | 2002-11-07 | 2006-09-19 | Access Business Group International Llc | Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors |
| ITMI20030391A1 (it) * | 2003-03-04 | 2004-09-05 | S I I T S R L Servizio Internaz Ionale Imballa | Formulazioni anticarie a base di faseolamina. |
| JP5285852B2 (ja) * | 2006-12-28 | 2013-09-11 | 株式会社ファンケル | Ｄｆａｉｉｉの製造方法及びｄｆａｉｉｉ高含有植物エキス |
| WO2009112054A1 (en) * | 2008-03-10 | 2009-09-17 | Phf S.A. | High bioavailability formulation of mangosteen and manufacturing process thereof |
| CA2751227C (en) * | 2009-02-02 | 2021-10-26 | Laila Nutraceuticals | Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome |
| JP2011079752A (ja) * | 2009-10-05 | 2011-04-21 | Kracie Home Products Ltd | 膵リパーゼ阻害剤並びにそれを含有する飲食品組成物及び医薬品組成物 |
| CN103478738B (zh) * | 2013-09-17 | 2016-02-10 | 深圳太太药业有限公司 | 一种具有减肥塑身及体重管理作用的组合物 |
| CN106686988A (zh) * | 2014-09-19 | 2017-05-17 | 雀巢产品技术援助有限公司 | 用于降低伴侣动物碳水化合物吸收的方法和配制物 |
| CN106036342A (zh) * | 2016-06-14 | 2016-10-26 | 安徽平唐微食疗科技有限公司 | 适合于糖尿病人群食用的膳食补充固体饮料及其制备方法 |
| IT201700078389A1 (it) * | 2017-07-13 | 2019-01-13 | Mv Medical Solutions | Composizione utile nella prevenzione o trattamento degli stati di malassorbimento secondari a chirurgia bariatrica in soggetti obesi. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4010258A (en) * | 1974-03-15 | 1977-03-01 | Ajinomoto Co., Inc. | Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus |
| JP2757405B2 (ja) * | 1988-12-09 | 1998-05-25 | 日清製粉株式会社 | 小麦から得られるα−アミラーゼインヒビターを含有するダイエット剤 |
| US5612039A (en) * | 1994-03-14 | 1997-03-18 | Nini E. Policappelli | Dietary supplement |
| DE60012301D1 (de) * | 1999-01-22 | 2004-08-26 | Hunza Di Pistolesi Elvira & C | Lipoproteinkomplexe und zusammensetzungen, die diese enthalten |
-
1999
- 1999-09-08 GB GBGB9921229.2A patent/GB9921229D0/en not_active Ceased
-
2000
- 2000-09-08 PT PT00958855T patent/PT1213972E/pt unknown
- 2000-09-08 AU AU70269/00A patent/AU777044B2/en not_active Ceased
- 2000-09-08 EP EP00958855A patent/EP1213972B1/en not_active Expired - Lifetime
- 2000-09-08 DK DK00958855T patent/DK1213972T3/da active
- 2000-09-08 ES ES00958855T patent/ES2199174T3/es not_active Expired - Lifetime
- 2000-09-08 KR KR1020027003087A patent/KR100594520B1/ko not_active IP Right Cessation
- 2000-09-08 NZ NZ518167A patent/NZ518167A/xx not_active IP Right Cessation
- 2000-09-08 WO PCT/GB2000/003472 patent/WO2001017369A1/en active IP Right Grant
- 2000-09-08 GB GB0127158A patent/GB2364498A/en not_active Withdrawn
- 2000-09-08 AT AT00958855T patent/ATE238689T1/de not_active IP Right Cessation
- 2000-09-08 CA CA002383720A patent/CA2383720A1/en not_active Abandoned
- 2000-09-08 DE DE60002484T patent/DE60002484T2/de not_active Expired - Fee Related
- 2000-09-08 JP JP2001521170A patent/JP2003508467A/ja not_active Withdrawn
-
2002
- 2002-03-08 NO NO20021160A patent/NO314922B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB9921229D0 (en) | 1999-11-10 |
| NO314922B1 (no) | 2003-06-16 |
| AU777044B2 (en) | 2004-09-30 |
| EP1213972B1 (en) | 2003-05-02 |
| DE60002484D1 (de) | 2003-06-05 |
| CA2383720A1 (en) | 2001-03-15 |
| ATE238689T1 (de) | 2003-05-15 |
| EP1213972A1 (en) | 2002-06-19 |
| GB2364498A (en) | 2002-01-30 |
| GB0127158D0 (en) | 2002-01-02 |
| DE60002484T2 (de) | 2004-03-18 |
| AU7026900A (en) | 2001-04-10 |
| PT1213972E (pt) | 2003-09-30 |
| ES2199174T3 (es) | 2004-02-16 |
| JP2003508467A (ja) | 2003-03-04 |
| WO2001017369A1 (en) | 2001-03-15 |
| NZ518167A (en) | 2003-03-28 |
| NO20021160L (no) | 2002-03-27 |
| KR20020045605A (ko) | 2002-06-19 |
| KR100594520B1 (ko) | 2006-07-19 |
| NO20021160D0 (no) | 2002-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1213972T3 (da) | Komposition omfattende en alfa-amylase-inhibitor og mindst en fysiologisk acceptabel forbindelse, der kan nedsætte absorptionen af "hurtigere sukkere" i tarmen | |
| BG104680A (en) | Celecoxib compositions | |
| DK0682664T3 (da) | Forbindelser med både potent calciumantagonist og antioxiderende aktivitet og anvendelse deraf som cytobeskyttende midler | |
| AU2002256093A1 (en) | Bulking agents as satiety agents | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| TR200100448T2 (tr) | Fenil ksantin türevleri | |
| HRP20041132A2 (en) | 7-aryl-3, 9-diazabicyclo (3.3.1) non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases | |
| HRP20050307A2 (en) | Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate | |
| RS20050470A (en) | Solid drug for oral use | |
| WO2004017998A3 (en) | Topical emulsion- gel composition comprising diclofenac sodium | |
| IL156827A (en) | Derivatives of 2-mercapto- [3,1] thiazolo [4,5 [b- pyridine and pharmaceutical preparations containing them for the treatment of cardiovascular disease | |
| EA200701068A1 (ru) | Применение антиоксидантных соединений для восстановления мышц | |
| GB2421241A (en) | Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof | |
| WO2004000045A3 (en) | Liquid compositions comprising non-digestible oligosaccharides and green tea catechins, method and uses thereof | |
| JP2003508467A5 (da) | ||
| SI1572182T1 (sl) | Sestavek za zdravljenje gastrointestinalnih motenj | |
| MXPA02011940A (es) | Estuches y metodos para optimizar la eficacia de composiciones condroprotectoras. | |
| EP1068868A3 (en) | Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration | |
| MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. | |
| IL150977A (en) | Use of protein source for preparation of a nutitional composition for maintaining or improving the synthesis of mucins | |
| SI1492521T1 (sl) | Kombinirana uporaba l-karnitina, acetil l-karnitina in propil l-karnitina za zdravljenje oligoastenoteratospermije | |
| IS6676A (is) | Amínóalkenýlbensóýl-bensófúran eða bensóþíófenafleiður, aðferð til framleiðslu þeirra og samsetningar sem innihalda þær | |
| RS20050272A (en) | Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate | |
| WO2003077831A3 (en) | Compositions and methods for treating mdma-induced toxicity | |
| MXPA04006269A (es) | Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes. |